Maternal dietary omega-3 fatty acid intake increases resolvin and protectin levels in the rat placenta

Journal of Lipid Research

Volumn 54, Issue 8, 2013, Pages 2247-2254

  Jones, Megan L ^a   Mark, Peter J ^a   Keelan, Jeffrey A ^a   Barden, Anne ^a   Mas, Emilie ^a   Mori, Trevor A ^a   Waddell, Brendan J ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Inflammation; Lipoxygenase; N 3PUFA; Pregnancy

Indexed keywords

ARACHIDONATE 5 LIPOXYGENASE; CD59 ANTIGEN; CYCLOOXYGENASE 1; DIHYDROXY DOCOSAHEXAENOIC ACID; DOCOSAHEXAENOIC ACID; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOXYGENASE; OMEGA 3 FATTY ACID; PROTEIN PRECURSOR; RESOLVIN; TRICHLORMETHINE; UNCLASSIFIED DRUG;

ALOX15B GENE; ALOX5 GENE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIET SUPPLEMENTATION; DIETARY INTAKE; FEMALE; FETUS; GENE; GENE EXPRESSION; GESTATIONAL AGE; MALE; MEDIATOR RELEASE; NONHUMAN; PLACENTA; PREGNANCY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RAT; REAL TIME POLYMERASE CHAIN REACTION;

EID: 84881233065     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M039842     Document Type: Article

References (42)

1. Calder, P. C. 2012.Long-chain fatty acids and inflammation. Proc. Nutr. Soc. 71 : 284-289.
2. Haggarty, P. 2010.Fatty acid supply to the human fetus. Annu. Rev. Nutr. 30 : 237-255.
3. Szajewska, H., A. Horvath, and B. Koletzko.2006.Effect of n-3 longchain polyunsaturated fatty acid supplementation of women with low-risk pregnancies on pregnancy outcomes and growth measures at birth: A meta-analysis of randomized controlled trials. Am. J. Clin. Nutr. 83 : 1337-1344.
4. Oken, E., Y. Ning, S. L. Rifas-Shiman, J. W. Rich-Edwards, S. F. Olsen, and M. W. Gillman.2007.Diet during pregnancy and risk of preeclampsia or gestational hypertension. Ann. Epidemiol. 17 : 663-668.
5. Olsen, S. F., N. J. Secher, A. Tabor, T. Weber, J. J. Walker, and C. Gluud.2000.Randomised clinical trials of fish oil supplementation in high risk pregnancies. Fish oil trials in pregnancy (FOTIP) team. BJOG.107 : 382-395.
6. Zhou, S. J., L. Yelland, A. J. McPhee, J. Quinlivan, R. A. Gibson, and M. Makrides.2012.Fish-oil supplementation in pregnancy does not reduce the risk of gestational diabetes or preeclampsia. Am. J. Clin. Nutr. 95 : 1378-1384.
7. Olsen, S. F., J. R. Olsen, and G. Frische.1990.Does fish consumption during pregnancy increase fetal growth? A study of the size of the newborn, placental weight and gestational age in relation to fish consumption during pregnancy. Int. J. Epidemiol. 19 : 971-977.
8. Jones, M. L., P. J. Mark, T. A. Mori, J. A. Keelan, and B. J. Waddell. 2013.Maternal dietary omega-3 fatty acid supplementation reduces placental oxidative stress and increases fetal and placental growth in the rat. Biol. Reprod. 88.In press.
9. Jawerbaum, A., and E. Capobianco.2011.Review: Effects of PPAR activation in the placenta and the fetus: Implications in maternal diabetes. Placenta.32 (Suppl. 2) : S212-S217.
10. Calder, P. C. 2003.n ? 3 Polyunsaturated fatty acids and inflammation: From molecular biology to the clinic. Lipids.38 : 343-352.
11. Calder, P. C. 2011.Fatty acids and inflammation: The cutting edge between food and pharma. Eur. J. Pharmacol. 668 (Suppl. 1) : S50-S58.
12. Serhan, C. N., and N. A. Petasis.2011.Resolvins and protectins in inflammation resolution. Chem. Rev. 111 : 5922-5943.
13. Serhan, C. N. 2007.Resolution phase of inflammation: Novel endogenous anti-Infl ammatory and proresolving lipid mediators and pathways. Annu. Rev. Immunol. 25 : 101-137.
14. Seki, H., Y. Tani, and M. Arita.2009.Omega-3 PUFA derived antiinflammatory lipid mediator resolvin E1. Prostaglandins Other Lipid Mediat. 89 : 126-130.
15. Serhan, C. N., C. B. Clish, J. Brannon, S. P. Colgan, N. Chiang, and K. Gronert.2000.Novel functional sets of lipid-derived mediators with antiinflammatory actions generated from omega-3 fatty acids via cyclooxygenase 2-nonsteroidal antiinflammatory drugs and transcellular processing. J. Exp. Med. 192 : 1197-1204.
16. Serhan, C. N., S. Hong, K. Gronert, S. P. Colgan, P. R. Devchand, G. Mirick, and R-L. Moussignac.2002.A family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals. J. Exp. Med. 196 : 1025-1037.
17. Weylandt, K. H., C-Y. Chiu, B. Gomolka, S. F. Waechter, and B. Wiedenmann.2012.Omega-3 fatty acids and their lipid mediators: Towards an understanding of resolvin and protectin formation. Prostaglandins Other Lipid Mediat. 97 : 73-82.
18. Gonzalez-Periz, A., A. Planaguma, K. Gronert, R. Miquel, M. Lopez-Parra, E. Titos, R. Horrillo, N. Ferre, R. Deulofeu, V. Arroyo, et al. 2006.Docosahexaenoic acid (DHA) blunts liver injury by conversion to protective lipid mediators: Protectin D1 and 17S-hydroxy-DHA. FASEB J. 20 : 2537-2539.
19. Poulsen, R. C., K. H. Gotlinger, C. N. Serhan, and M. C. Kruger. 2008.Identification of inflammatory and proresolving lipid mediators in bone marrow and their lipidomic profiles with ovariectomy and omega-3 intake. Am. J. Hematol. 83 : 437-445.
20. Oh, S. F., P. S. Pillai, A. Recchiuti, R. Yang, and C. N. Serhan. 2011.Pro-resolving actions and stereoselective biosynthesis of 18S E-series resolvins in human leukocytes and murine inflammation. J. Clin. Invest. 121 : 569-581.
21. Arita, M., F. Bianchini, J. Aliberti, A. Sher, N. Chiang, S. Hong, R. Yang, N. A. Petasis, and C. N. Serhan.2005.Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1. J. Exp. Med. 201 : 713-722.
22. Mark, P. J., S. Augustus, J. L. Lewis, D. P. Hewitt, and B. J. Waddell. 2009.Changes in the placental glucocorticoid barrier during rat pregnancy: Impact on placental corticosterone levels and regulation by progesterone. Biol. Reprod. 80 : 1209-1215.
23. Imperato-McGinley, J., Z. Binienda, J. Gedney, and E. D. J. Vaughan. 1986.Nipple differentiation in fetal male rats treated with an inhibitor of the enzyme 5{alpha}-reductase: Definition of a selective role for dihydrotestosterone. Endocrinology.118 : 132-137.
24. Mas, E., K. D. Croft, P. Zahra, A. Barden, and T. A. Mori.2012. Resolvins D1, D2, and other mediators of self-limited resolution of inflammation in human blood following n-3 fatty acid supplementation. Clin. Chem. 58 : 1476-1484.
25. Sun, Y-P., S. F. Oh, J. Uddin, R. Yang, K. Gotlinger, E. Campbell, S. P. Colgan, N. A. Petasis, and C. N. Serhan.2007.Resolvin D1 and its aspirin-triggered 17R epimer: Stereochemical assignments, antiinflammatory properties, and enzymatic inactivation. J. Biol. Chem. 282 : 9323-9334.
26. Spite, M., L. V. Norling, L. Summers, R. Yang, D. Cooper, N. A. Petasis, R. J. Flower, M. Perretti, and C. N. Serhan.2009.Resolvin D2 is a potent regulator of leukocytes and controls microbial sepsis. Nature.461 : 1287-1291.
27. Serhan, C. N., K. Gotlinger, S. Hong, Y. Lu, J. Siegelman, T. Baer, R. Yang, S. P. Colgan, and N. A. Petasis.2006.Anti-inflammatory actions of neuroprotectin d1/protectin d1 and its natural stereoisomers: Assignments of dihydroxy-containing docosatrienes. J. Immunol. 176 : 1848-1859.
28. Rozen, S., and H. Skaletsky.2000.Primer3 on the WWW for general users and for biologist programmers. Methods Mol. Biol. 132 : 365-386.
29. Vandesompele, J., K. D. Preter, F. Pattyn, B. Poppe, N. V. Roy, A. D. Paepe, and F. Speleman.2002.Accurate normalization of realtime quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 3: RESEARCH0034.
30. Snedecor, G., and W. Cochran.1989.Statistical Methods. 8 th edition. Iowa State University Press, Ames, IA.
31. Claria, J., B. T. Nguyen, A. Madenci, C. K. Ozaki, and C. N. Serhan. Diversity of lipid mediators in human adipose tissue depots. Am. J. Physiol. Cell Physiol. Epub ahead of print. January 30, 2013; doi:10.1152/ajpcell.00351. 2012.
32. Challis, J. R., C. J. Lockwood, L. Myatt, J. E. Norman, J. F. Strauss, and F. Petraglia.2009.Inflammation and pregnancy. Reprod. Sci. 16 : 206-215.
33. Chiu, C-Y., B. Gomolka, C. Dierkes, N. R. Huang, M. Schroeder, M. Purschke, D. Manstein, B. Dangi, and K. H. Weylandt.2012. Omega-6 docosapentaenoic acid-derived resolvins and 17-hydroxydocosahexaenoic acid modulate macrophage function and alleviate experimental colitis. Infl amm. Res. 61 : 967-976.
34. Krishnamurthy, V. R., A. Dougherty, C. A. Haller, and E. L. Chaikof. 2011.Total synthesis and bioactivity of 18(R)-hydroxyeicosapentaenoic acid. J. Org. Chem. 76 : 5433-5437.
35. Weylandt, K. H., L. F. Krause, B. Gomolka, C-Y. Chiu, S. l. Bilal, A. Nadolny, S. F. Waechter, A. Fischer, M. Rothe, and J. X. Kang. 2011.Suppressed liver tumorigenesis in fat-1 mice with elevated omega-3 fatty acids is associated with increased omega-3 derived lipid mediators and reduced TNF-a. Carcinogenesis.32 : 897-903.
36. Krishnamoorthy, S., A. Recchiuti, N. Chiang, S. T. Yacoubian, C-H. Lee, R. Yang, N. A. Petasis, and C. N. Serhan.2010.Resolvin D1 binds human phagocytes with evidence for proresolving receptors. Proc. Natl. Acad. Sci. USA.107 : 1660-1665.
37. Arita, M., T. Ohira, Y-P. Sun, S. Elangovan, N. Chiang, and C. N. Serhan.2007.Resolvin E1 selectively interacts with leukotriene B4 receptor BLT1 and ChemR23 to regulate inflammation. J. Immunol. 178 : 3912-3917.
38. Takata, K., K. Fujikura, and B. C. Shin.1997.Ultrastructure of the rodent placental labyrinth: A site of barrier and transport. J. Reprod. Dev. 43 : 13-24.
39. Paulesu, L., J. Bhattacharjee, N. Bechi, R. Romagnoli, S. Jantra, and F. Ietta.2010.Pro-inflammatory cytokines in animal and human gestation. Curr. Pharm. Des. 16 : 3601-3615.
40. Keelan, J. A., M. Blumenstein, R. J. A. Helliwell, T. A. Sato, K. W. Marvin, and M. D. Mitchell.2003.Cytokines, prostaglandins and parturition-a review. Placenta.24 : S33-S46.
41. Vandevyver, S., L. Dejager, J. Tuckermann, and C. Libert.2013. New insights into the anti-inflammatory mechanisms of glucocorticoids: An emerging role for glucocorticoid-receptor-mediated transactivation. Endocrinology.154 : 993-1007.
42. Mark, P. J., J. L. Lewis, M. L. Jones, J. A. Keelan, and B. J. Waddell. 2013.The inflammatory state of the rat placenta increases in late gestation and is further enhanced by glucocorticoids in the labyrinth zone. Placenta.34: 559-566.